Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 463

1.

Journal Watch: our panel of experts highlight the most important research articles across the spectrum of topics relevant to the field of melanoma management.

Rawson RV, Bailey T, Colebatch AJ, Ferguson P.

Melanoma Manag. 2019 Jun 14;6(1):MMT18. doi: 10.2217/mmt-2019-0002. No abstract available.

2.

Improving diagnostic accuracy for suspicious melanocytic skin lesions: New Australian melanoma clinical practice guidelines stress the importance of clinician/pathologist communication.

Scolyer RA, Soyer HP, James C, McLean CA, Coventry BJ, Ferguson PM, Rawson RV, Mar VJ, de Menezes SL, Fishburn P, Stretch JR, Lee S, Thompson JF, Kelly JW.

Aust J Gen Pract. 2019 Jun;48(6):357-362.

PMID:
31220881
3.

Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial.

Long GV, Saw RPM, Lo S, Nieweg OE, Shannon KF, Gonzalez M, Guminski A, Lee JH, Lee H, Ferguson PM, Rawson RV, Wilmott JS, Thompson JF, Kefford RF, Ch'ng S, Stretch JR, Emmett L, Kapoor R, Rizos H, Spillane AJ, Scolyer RA, Menzies AM.

Lancet Oncol. 2019 Jul;20(7):961-971. doi: 10.1016/S1470-2045(19)30331-6. Epub 2019 Jun 3.

PMID:
31171444
4.

Development and Application of a Functional Human Esophageal Mucosa Explant Platform to Eosinophilic Esophagitis.

Kurten RC, Rawson R, Shoda T, Duong LD, Adejumobi D, Levy R, Newbury RO, Rothenberg ME, Akuthota P, Wright BL, Dohil R, Jones SM, Aceves SS.

Sci Rep. 2019 Apr 17;9(1):6206. doi: 10.1038/s41598-019-41147-8.

5.

Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas.

Quek C, Rawson RV, Ferguson PM, Shang P, Silva I, Saw RPM, Shannon K, Thompson JF, Hayward NK, Long GV, Mann GJ, Scolyer RA, Wilmott JS.

Oncotarget. 2019 Jan 29;10(9):930-941. doi: 10.18632/oncotarget.26584. eCollection 2019 Jan 29.

6.

A teenager with a black nodule on the buttock.

Wong XL, Rawson RV, Sebaratnam DF.

J Paediatr Child Health. 2019 Feb;55(2):240. doi: 10.1111/jpc.1_14302. No abstract available.

PMID:
30746881
7.

Assessment of medication for opioid use disorder as delivered within the Vermont hub and spoke system.

Rawson R, Cousins SJ, McCann M, Pearce R, Van Donsel A.

J Subst Abuse Treat. 2019 Feb;97:84-90. doi: 10.1016/j.jsat.2018.11.003. Epub 2018 Nov 19.

PMID:
30577904
8.

Using behaviour change and implementation science to address low referral rates in oncology.

Long JC, Debono D, Williams R, Salisbury E, O'Neill S, Eykman E, Butler J, Rawson R, Phan-Thien KC, Thompson SR, Braithwaite J, Chin M, Taylor N.

BMC Health Serv Res. 2018 Nov 28;18(1):904. doi: 10.1186/s12913-018-3653-1.

9.

Interleukin 9 Alters Epithelial Barrier and E-cadherin in Eosinophilic Esophagitis.

Doshi A, Khamishon R, Rawson R, Duong L, Dohil L, Myers SJ, Bell B, Dohil R, Newbury RO, Barrett KE, Kurten RC, Aceves SS.

J Pediatr Gastroenterol Nutr. 2019 Feb;68(2):225-231. doi: 10.1097/MPG.0000000000002144.

PMID:
30211842
10.

Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma.

Tetzlaff MT, Messina JL, Stein JE, Xu X, Amaria RN, Blank CU, van de Wiel BA, Ferguson PM, Rawson RV, Ross MI, Spillane AJ, Gershenwald JE, Saw RPM, van Akkooi ACJ, van Houdt WJ, Mitchell TC, Menzies AM, Long GV, Wargo JA, Davies MA, Prieto VG, Taube JM, Scolyer RA.

Ann Oncol. 2018 Aug 1;29(8):1861-1868. doi: 10.1093/annonc/mdy226.

PMID:
29945191
11.

Change in anxiety sensitivity and substance use coping motives as putative mediators of treatment efficacy among substance users.

Wolitzky-Taylor K, Drazdowski TK, Niles A, Roy-Byrne P, Ries R, Rawson R, Craske MG.

Behav Res Ther. 2018 Aug;107:34-41. doi: 10.1016/j.brat.2018.05.010. Epub 2018 May 24.

PMID:
29852309
12.

Who needs more than standard care? Treatment moderators in a randomized clinical trial comparing addiction treatment alone to addiction treatment plus anxiety disorder treatment for comorbid anxiety and substance use disorders.

Wolitzky-Taylor K, Niles AN, Ries R, Krull JL, Rawson R, Roy-Byrne P, Craske M.

Behav Res Ther. 2018 Aug;107:1-9. doi: 10.1016/j.brat.2018.05.005. Epub 2018 May 17.

PMID:
29800622
13.

The smart approach: feasibility of lentigo maligna superficial margin assessment with hand-held reflectance confocal microscopy technology.

Pellacani G, De Carvalho N, Ciardo S, Ferrari B, Cesinaro AM, Farnetani F, Bassoli S, Guitera P, Star P, Rawson R, Rossi E, Magnoni C, Gualdi G, Longo C, Scope A.

J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1687-1694. doi: 10.1111/jdv.15033. Epub 2018 May 27.

PMID:
29704275
14.

Randomized clinical trial evaluating the preliminary effectiveness of an integrated anxiety disorder treatment in substance use disorder specialty clinics.

Wolitzky-Taylor K, Krull J, Rawson R, Roy-Byrne P, Ries R, Craske MG.

J Consult Clin Psychol. 2018 Jan;86(1):81-88. doi: 10.1037/ccp0000276.

15.

Effectiveness of extended release naltrexone to reduce alcohol cravings and use behaviors during treatment and at follow-up.

Crèvecoeur-MacPhail D, Cousins SJ, Denering L, Kim T, Rawson RA.

J Subst Abuse Treat. 2018 Feb;85:105-108. doi: 10.1016/j.jsat.2017.11.004. Epub 2017 Nov 10.

PMID:
29174308
16.

Cost-Effectiveness of Publicly Funded Treatment of Opioid Use Disorder in California.

Krebs E, Enns B, Evans E, Urada D, Anglin MD, Rawson RA, Hser YI, Nosyk B.

Ann Intern Med. 2018 Jan 2;168(1):10-19. doi: 10.7326/M17-0611. Epub 2017 Nov 21.

PMID:
29159398
17.

PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors.

Kakavand H, Rawson RV, Pupo GM, Yang JYH, Menzies AM, Carlino MS, Kefford RF, Howle JR, Saw RPM, Thompson JF, Wilmott JS, Long GV, Scolyer RA, Rizos H.

Clin Cancer Res. 2017 Oct 15;23(20):6054-6061. doi: 10.1158/1078-0432.CCR-16-1688. Epub 2017 Jul 19.

18.

Germline BAP1 mutations also predispose to cutaneous squamous cell carcinoma.

Rawson RV, Watson GF, Maher AM, McCarthy SW, Thompson JF, Scolyer RA.

Pathology. 2017 Aug;49(5):539-542. doi: 10.1016/j.pathol.2017.03.005. Epub 2017 Jul 8. No abstract available.

PMID:
28693747
19.

Recurrent bowel obstruction: unusual presentation of pembrolizumab-induced pancreatitis in annular pancreas.

Rawson RV, Robbins E, Kapoor R, Scolyer RA, Long GV.

Eur J Cancer. 2017 Sep;82:167-170. doi: 10.1016/j.ejca.2017.05.042. Epub 2017 Jul 6. No abstract available.

PMID:
28689094
20.

Examining Hippocampal Mossy Fiber Synapses by 3D Electron Microscopy in Wildtype and Kirrel3 Knockout Mice.

Martin EA, Woodruff D, Rawson RL, Williams ME.

eNeuro. 2017 Jun 19;4(3). pii: ENEURO.0088-17.2017. doi: 10.1523/ENEURO.0088-17.2017. eCollection 2017 May-Jun.

21.

Barriers to initiation of extended release naltrexone among HIV-infected adults with alcohol use disorders.

Chokron Garneau H, Venegas A, Rawson R, Ray LA, Glasner S.

J Subst Abuse Treat. 2018 Feb;85:34-37. doi: 10.1016/j.jsat.2017.05.004. Epub 2017 May 11.

22.

National Rehabilitation Center programme performance measures in the United Arab Emirates, 2013.

Elkashef A, Alhyas L, Al Hashmi H, Mohammed D, Gonzalez A, Paul R, Wanigaratne S, Gawad T, Rawson R, Al Marzooqi A, Al Ghaferi H.

East Mediterr Health J. 2017 May 1;23(3):182-188.

23.

Mechanisms of input and output synaptic specificity: finding partners, building synapses, and fine-tuning communication.

Rawson RL, Martin EA, Williams ME.

Curr Opin Neurobiol. 2017 Aug;45:39-44. doi: 10.1016/j.conb.2017.03.006. Epub 2017 Apr 5. Review.

24.

The Los Angeles County hub-and-provider network for promoting the sustained use of extended-release naltrexone (XR-NTX) in Los Angeles County (2010-2015).

Cousins SJ, Crèvecoeur-MacPhail D, Kim T, Rawson RA.

J Subst Abuse Treat. 2018 Feb;85:78-83. doi: 10.1016/j.jsat.2017.02.011. Epub 2017 Mar 11.

PMID:
28291571
25.

Self-reported substance use in Iraq: findings from the Iraqi National Household Survey of Alcohol and Drug Use, 2014.

Al-Hemiery N, Dabbagh R, Hashim MT, Al-Hasnawi S, Abutiheen A, Abdulghani EA, Al-Diwan JK, Kak N, Al Mossawi H, Maxwell JC, Brecht ML, Antonini V, Hasson A, Rawson RA.

Addiction. 2017 Aug;112(8):1470-1479. doi: 10.1111/add.13800. Epub 2017 Apr 7.

PMID:
28238214
26.

Mindfulness Based Relapse Prevention for Stimulant Dependent Adults: A Pilot Randomized Clinical Trial.

Glasner-Edwards S, Mooney LJ, Ang A, Garneau HC, Hartwell E, Brecht ML, Rawson RA.

Mindfulness (N Y). 2017 Feb;8(1):126-135. doi: 10.1007/s12671-016-0586-9. Epub 2016 Aug 4.

27.

Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas.

Rawson RV, Johansson PA, Hayward NK, Waddell N, Patch AM, Lo S, Pearson JV, Thompson JF, Mann GJ, Scolyer RA, Wilmott JS.

Lab Invest. 2017 Feb;97(2):130-145. doi: 10.1038/labinvest.2016.143. Epub 2017 Jan 9.

28.

Trends in Tramadol: Pharmacology, Metabolism, and Misuse.

Miotto K, Cho AK, Khalil MA, Blanco K, Sasaki JD, Rawson R.

Anesth Analg. 2017 Jan;124(1):44-51. Review.

PMID:
27861439
29.

Angiomatoid Spitz naevus: novel observations and clues to diagnosis of a rare variant.

Rawson R, Robbins E, McCarthy SW, Scolyer RA.

Pathology. 2016 Dec;48(7):739-742. doi: 10.1016/j.pathol.2016.08.015. Epub 2016 Oct 22. No abstract available.

PMID:
27780602
30.

Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users.

Kohno M, Okita K, Morales AM, Robertson CL, Dean AC, Ghahremani DG, Sabb FW, Rawson RA, Mandelkern MA, Bilder RM, London ED.

Mol Psychiatry. 2016 Nov;21(11):1554-1560. doi: 10.1038/mp.2015.223. Epub 2016 Feb 2.

31.

Organizing Publicly Funded Substance Use Disorder Treatment in the United States: Moving Toward a Service System Approach.

Padwa H, Urada D, Gauthier P, Rieckmann T, Hurley B, Crèvecouer-MacPhail D, Rawson RA.

J Subst Abuse Treat. 2016 Oct;69:9-18. doi: 10.1016/j.jsat.2016.06.010. Epub 2016 Jun 29.

PMID:
27568505
32.

A Cognitive Behavioral Therapy-Based Text Messaging Intervention Versus Medical Management for HIV-Infected Substance Users: Study Protocol for a Pilot Randomized Trial.

Glasner-Edwards S, Patrick K, Ybarra ML, Reback CJ, Rawson RA, Chokron Garneau H, Chavez K, Venegas A.

JMIR Res Protoc. 2016 Jun 24;5(2):e131. doi: 10.2196/resprot.5407.

33.

TGF-β1-induced PAI-1 contributes to a profibrotic network in patients with eosinophilic esophagitis.

Rawson R, Yang T, Newbury RO, Aquino M, Doshi A, Bell B, Broide DH, Dohil R, Kurten R, Aceves SS.

J Allergy Clin Immunol. 2016 Sep;138(3):791-800.e4. doi: 10.1016/j.jaci.2016.02.028. Epub 2016 Apr 8.

34.

Growth hormone secreting pituitary adenoma with admixed gangliocytoma and ganglioglioma.

Jukes A, Allan R, Rawson R, Buckland ME.

J Clin Neurosci. 2016 Sep;31:202-4. doi: 10.1016/j.jocn.2016.02.024. Epub 2016 Apr 8.

PMID:
27068013
35.

Predictors of Continued Use of Extended-Released Naltrexone (XR-NTX) for Opioid-Dependence: An Analysis of Heroin and Non-Heroin Opioid Users in Los Angeles County.

Cousins SJ, Radfar SR, Crèvecoeur-MacPhail D, Ang A, Darfler K, Rawson RA.

J Subst Abuse Treat. 2016 Apr;63:66-71. doi: 10.1016/j.jsat.2015.12.004. Epub 2015 Dec 29.

PMID:
26823295
36.

The TGFβ1 Promoter SNP C-509T and Food Sensitization Promote Esophageal Remodeling in Pediatric Eosinophilic Esophagitis.

Rawson R, Anilkumar A, Newbury RO, Bafna V, Aquino M, Palmquist J, Hoffman HM, Mueller JL, Dohil R, Broide DH, Aceves SS.

PLoS One. 2015 Dec 14;10(12):e0144651. doi: 10.1371/journal.pone.0144651. eCollection 2015.

37.

Rigid substrate induces esophageal smooth muscle hypertrophy and eosinophilic esophagitis fibrotic gene expression.

Tkachenko E, Rawson R, La E, Doherty TA, Baum R, Cavagnero K, Miyanohara A, Dohil R, Kurten RC, Aceves SS.

J Allergy Clin Immunol. 2016 Apr;137(4):1270-1272.e1. doi: 10.1016/j.jaci.2015.09.020. Epub 2015 Nov 2. No abstract available.

38.

Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment.

Robertson CL, Ishibashi K, Chudzynski J, Mooney LJ, Rawson RA, Dolezal BA, Cooper CB, Brown AK, Mandelkern MA, London ED.

Neuropsychopharmacology. 2016 May;41(6):1629-36. doi: 10.1038/npp.2015.331. Epub 2015 Oct 27.

39.

Impact of an exercise intervention on methamphetamine use outcomes post-residential treatment care.

Rawson RA, Chudzynski J, Mooney L, Gonzales R, Ang A, Dickerson D, Penate J, Salem BA, Dolezal B, Cooper CB.

Drug Alcohol Depend. 2015 Nov 1;156:21-28. doi: 10.1016/j.drugalcdep.2015.08.029. Epub 2015 Sep 3.

40.

A demonstration project implementing extended-release naltrexone in Los Angeles County.

Cousins SJ, Denering L, Crèvecoeur-MacPhail D, Viernes J, Sugita W, Barger J, Kim T, Weimann S, Rawson RA.

Subst Abus. 2016;37(1):54-62. doi: 10.1080/08897077.2015.1052868. Epub 2015 Jul 9.

PMID:
26158698
41.
42.

The Impact of Exercise On Depression and Anxiety Symptoms Among Abstinent Methamphetamine-Dependent Individuals in A Residential Treatment Setting.

Rawson RA, Chudzynski J, Gonzales R, Mooney L, Dickerson D, Ang A, Dolezal B, Cooper CB.

J Subst Abuse Treat. 2015 Oct;57:36-40. doi: 10.1016/j.jsat.2015.04.007. Epub 2015 Apr 15.

43.

Predictors of depression outcomes among abstinent methamphetamine-dependent individuals exposed to an exercise intervention.

Haglund M, Ang A, Mooney L, Gonzales R, Chudzynski J, Cooper CB, Dolezal BA, Gitlin M, Rawson RA.

Am J Addict. 2015 Apr;24(3):246-51. doi: 10.1111/ajad.12175.

PMID:
25907813
44.

The globalization of addiction research: capacity-building mechanisms and selected examples.

Rawson RA, Woody G, Kresina TF, Gust S.

Harv Rev Psychiatry. 2015 Mar-Apr;23(2):147-56. doi: 10.1097/HRP.0000000000000067. Review.

46.

Substance use disorders and HIV in Vietnam since Doi Moi (Renovation): an overview.

Giang LM, Ngoc LB, Hoang VH, Mulvey K, Rawson RA.

J Food Drug Anal. 2013 Dec;21(4):S42-S45.

48.

Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in publicly-funded facilities in California, USA: 1991-2012.

Nosyk B, Li L, Evans E, Urada D, Huang D, Wood E, Rawson R, Hser YI.

Drug Alcohol Depend. 2014 Oct 1;143:149-57. doi: 10.1016/j.drugalcdep.2014.07.020. Epub 2014 Jul 27.

49.

Drug and alcohol use in Iraq: findings of the inaugural Iraqi Community Epidemiological Workgroup.

Al-Hemiary NJ, Al-Diwan JK, Hasson AL, Rawson RA.

Subst Use Misuse. 2014 Nov;49(13):1759-63. doi: 10.3109/10826084.2014.913633. Epub 2014 May 14.

50.

Integration of substance use disorder services with primary care: health center surveys and qualitative interviews.

Urada D, Teruya C, Gelberg L, Rawson R.

Subst Abuse Treat Prev Policy. 2014 Mar 28;9:15. doi: 10.1186/1747-597X-9-15.

Supplemental Content

Loading ...
Support Center